David Kupfer, | Board of Directors | Minerva Neurosciences, Inc.

Skip to main navigation

Focus & Strategy
Innovation & Pipeline
Disease Areas
Investors & Media
Contact

Focus & Strategy

President’s Letter
Leadership
Board of Directors

Innovation & Pipeline

Roluperidone (MIN-101)
Seltorexant (MIN-202)
MIN-301

Schizophrenia
Insomnia and Mood Disorders
Parkinson’s Disease

Investors & Media

Press Releases
Events & Presentations
Corporate Governance
Financials & Filings
Stock Information
Investor FAQs
Contact Us

Corporate Governance

Executive Management
Board of Directors
Committee Composition
Contact the Board

Financials & Filings

SEC Filings
Annual Reports and Proxies
Quarterly Results
Key Ratios

Stock Information

Historic Stock Lookup
Investment Calculator
Analyst Coverage

Focus & Strategy
Innovation & Pipeline
Disease Areas
Investors & Media
Contact

INVESTORS & MEDIA

Press Releases
Events & Presentations
Corporate Governance
Financials & Filings
Stock Information
Investor FAQs
Contact Us

Shareholder Tools

Printed Materials

Email Alerts

RSS

RSS

David Kupfer, M.D.

Chair of the Nominating and Governance Committee
Member of the Compensation Committee
Member of the Audit Committee

Shareholder Tools

Printed Materials

Email Alerts

RSS

RSS

About Us

President's Letter
Leadership
Board of Directors

Disease Areas

Schizophrenia
Insomnia and Mood Disorders
Parkinson’s Disease

Innovation & Pipeline

Roluperidone (MIN-101)
Seltorexant (MIN-202)
MIN-301

(617) 600-7373
email us
Privacy Policy | Terms of Use

©2024 Minerva Neurosciences